Clinical Trial Update: Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy, safety, and tolerability of AZD8529 in adults with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• AZD8529

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED